Clinical Trials
39
Active:26
Completed:3
Trial Phases
3 Phases
Phase 1:32
Phase 2:2
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (38 trials with phase data)• Click on a phase to view related trials
Phase 1
32 (84.2%)Phase 2
2 (5.3%)Phase 3
2 (5.3%)phase_1_2
1 (2.6%)phase_2_3
1 (2.6%)No trials found
News
UCLA Researchers Receive $950,000 Grant to Launch Multi-Institutional Trial of Zipalertinib for EGFR-Mutated Cancers
UCLA's Arjan Gower received a $950,000 grant from the National Comprehensive Cancer Network and Taiho Oncology Inc. to launch a multi-institutional clinical trial testing zipalertinib.